FDAnews
www.fdanews.com/articles/114464-amgen-wins-european-approval-for-blood-platelet-drug

Amgen Wins European Approval for Blood Platelet Drug

February 9, 2009
Amgen has announced that the European Commission has granted marketing authorization for Nplate for the treatment of splenectomized adult chronic immune thrombocytopenic purpura patients who are refractory to other treatments.
TradingMarkets